Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

Tuberculosis is the infectious disease with the highest death rate worldwide. As reported by WHO, therapy-resistant tuberculosis infections are increasing. Diseases due to this bacterial infection may ...

A promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB). TB accounts for more than 1.6 million deaths worldwide ...

Researchers compare the impacts of cART by itself versus cART plus the IDO inhibitor in lung tissue of nonhuman primates with both TB and SIV. Left: Following just cART, significantly more IDO is ...

Researchers from the faculty of medicine at the University of Ottawa and their international collaborators say they have shown proof-of-concept for a new therapeutic approach in treating tuberculosis ...

Introduction Towards the ‘End TB Strategy’ targets, the WHO recommends the provision of tuberculosis (TB) preventive therapy (TPT) for high-risk groups including people living with HIV (PLWH). 3 years ...

A recent study published by researchers at Baylor College of Medicine and Texas Children’s Hospital, in collaboration with the German Center for Infection Research, identified two main subtypes or ...

A promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB). Scientists at Texas Biomedical Research Institute ...

Simple markers of anemia and systemic inflammation may be important tools for identifying patients with human immunodeficiency virus (HIV) infection who are at higher risk for active tuberculosis (TB) ...

A therapy showing promise to help control tuberculosis does not interfere with combined antiretroviral therapy (cART), according to new research. A therapy showing promise to help control tuberculosis ...